Abstract:Purpose: The leucine zipper-EF-hand containing transmembrane protein 1 (LETM1) is a mitochondrial protein that has been associated with the occurrence and development of malignant tumors. Previous studies have shown that LETM1 expression is increased in several types of human cancer and is associated with a poor clinical outcome. However, the role of LETM1 in prostate cancer (PCa) has not yet been determined. In this study, we investigated the clinicopathological significance of LETM1 expression and its role in PCa progression. Methods: We assessed the expression of LETM1 and genes related to cancer sternness, epithelial-mesenchymal transition (EMT), cell cycle, and PI3K/Akt signaling in 133 paraffin-embedded PCa tissue samples and cancer cells by using immunohistochemistry, immunofluorescence, and Western blotting. Results: LETM1 expression was significantly increased in PCa, and it was positively correlated with Gleason score, pathologic tumor (pT) stage, clinical stage, and high micro-vessel density. Survival analysis showed that patients with PCa with a high level of LETM1 expression exhibited a low overall survival. Cox regression analysis indicated that LETM1 is an independent poor prognostic PCa factor. Additionally, the expression of LETM1 was correlated with cancer cell sternness-associated genes, EMT-related genes, cell cycle regulatory genes, and PI3K/Akt signaling gene expression in PCa. Furthermore, knocking down LETM1 expression down-regulated the expression of sternness-related proteins, while inhibiting tumor spheroid formation, EMT-like changes, cell proliferation, migration, and invasion in PCa cells. Importantly, the PI3K inhibitor LY294002 strongly inhibited the expression of LETM1, pPI3K-p85, and pAkt (Thr308, Ser473) in PCa cells. Conclusion: These results indicate that LETM1 expression is associated with cancer cell stemness, promotes EMT-like changes and cell proliferation and is a potential prognostic biomarker for PCa.

LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis Through HB-EGF Shedding and EGFR-Mediated ERK Signaling

LIV-1 Enhances the Aggressive Phenotype Through the Induction of Epithelial to Mesenchymal Transition in Human Pancreatic Carcinoma Cells.

The zinc transporter LIV-1 is a novel regulator of stemness in pancreatic cancer cells.

Livin Mediates Tumor Cell Invasion in the DU-145 Cell Line Via NF-κB.

Livin regulates prostate cancer cell invasion by impacting the NF-κB signaling pathway and the expression of FN and CXCR4.

LRG1 Modulates Epithelial-Mesenchymal Transition and Angiogenesis in Colorectal Cancer Via HIF-1α Activation

The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer

Zinc Sensitizes Prostate Cancer Cells to Sorafenib and Regulates the Expression of Livin

Livin-Alpha Promotes Cell Proliferation By Regulating G(1)-S Cell Cycle Transition In Prostate Cancer

Vascular Endothelial Growth Factor Regulates Myeloid Cell Leukemia-1 Expression Through Neuropilin-1-dependent Activation of C-Met Signaling in Human Prostate Cancer Cells

Livin expression may be regulated by miR-198 in human prostate cancer cell lines.

LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway.

Livin Promotes the Progression and Metastasis of Breast Cancer Through the Regulation of Epithelial‑mesenchymal Transition Via the P38/gsk3β Pathway.

PrLZ Regulates EMT and Invasion in Prostate Cancer Via the TGF-β1/p-smad2/miR-200 Family/zeb1 Axis

Role of LRG1 in the Cell Proliferation, Migration, and Prognosis of Pancreatic Cancer

VEGF Stimulation Enhances Livin Protein Synthesis Through Mtor Signaling

LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression

Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer

LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling

Overexpression of Livin Promotes Migration and Invasion of Colorectal Cancer Cells by Induction of Epithelial–mesenchymal Transition Via NF-κB Activation

Long Noncoding RNA ZEB1-AS1 Epigenetically Regulates the Expressions of ZEB1 and Downstream Molecules in Prostate Cancer